Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 52 (5), 972-81

Inhibition of the Chemokine (C-C Motif) Ligand 2/chemokine (C-C Motif) Receptor 2 Pathway Attenuates Hyperglycaemia and Inflammation in a Mouse Model of Hepatic Steatosis and Lipoatrophy

Affiliations

Inhibition of the Chemokine (C-C Motif) Ligand 2/chemokine (C-C Motif) Receptor 2 Pathway Attenuates Hyperglycaemia and Inflammation in a Mouse Model of Hepatic Steatosis and Lipoatrophy

S J Yang et al. Diabetologia.

Abstract

Aims/hypothesis: Using a mouse model of lipoatrophic diabetes, we hypothesised that the chemokine (C-C motif) ligand 2 (CCL2)/chemokine (C-C motif) receptor 2 (CCR2) pathway contributes to hepatic macrophage accumulation and insulin resistance through induction of a chronic inflammatory state.

Methods: Metabolic variables of insulin resistance and inflammation were characterised in wild-type and lipoatrophic A-ZIP/F-1 transgenic (AZIP-Tg) mice. The AZIP-Tg mice were then treated with a CCR2 antagonist (RS504393, 2 mg kg(-1) day(-1)) or vehicle for 28 days via a subcutaneous mini-osmotic pump to examine the role of the CCL2/CCR2 pathway in lipoatrophic diabetes.

Results: The lipoatrophic AZIP-Tg mice were diabetic with high fasting glucose and serum insulin concentrations compared with littermate controls. The livers of AZIP-Tg mice were more than threefold enlarged and exhibited increased triacylglycerol content. CCL2 levels were highly elevated in both liver and serum of the AZIP-Tg mice compared with controls. In addition, the circulating CCL2 concentration was associated with increased macrophage accumulation and inflammation as documented by upregulation of Cd68 gene and Tnf-alpha [also known as Tnf] gene in livers from the AZIP-Tg mice. Treatment of the lipoatrophic AZIP-Tg mice with the CCR2 antagonist ameliorated the hyperglycaemia, hyperinsulinaemia and hepatomegaly in conjunction with a reduction in liver inflammation.

Conclusions/interpretation: These findings demonstrate a significant role of the CCL2/CCR2 pathway in lipoatrophy-induced diabetes and provide clear evidence that metabolic improvements resulting from the inhibition of this inflammatory pathway are not adipose tissue-dependent.

Similar articles

See all similar articles

Cited by 23 PubMed Central articles

See all "Cited by" articles

References

    1. Acta Paediatr Suppl. 1996 Jun;413:2-28 - PubMed
    1. J Hepatol. 2006 Jun;44(6):1167-74 - PubMed
    1. Arterioscler Thromb Vasc Biol. 2008 Dec;28(12):2195-201 - PubMed
    1. J Am Soc Nephrol. 2003 Oct;14(10):2503-15 - PubMed
    1. Int J Obes (Lond). 2006 Sep;30(9):1347-55 - PubMed

Publication types

MeSH terms

LinkOut - more resources

Feedback